Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors
Open Access
- 1 May 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (5), 1085-1089
- https://doi.org/10.1128/aac.38.5.1085
Abstract
Sixteen Escherichia coli clinical isolates which were resistant to ampicillin and amoxicillin-clavulanate but susceptible to cephalothin were studied. Eight strains showed the presence of a beta-lactamase which comigrates with reference OXA-1 enzyme. The eight other strains produced different TEM-1 derivatives which had in common a higher Km for penicillins and a higher 50% inhibitory concentration for the beta-lactamase inhibitors. By oligotyping and sequencing of PCR products, it was shown that Ser (AGC) (TEM-30; also called TRI-1) in three strains and Cys (TGC) (TEM-31; also called TRI-2) in one strain were substituted for Arg-241 (CGC), that Leu (CTG) (TEM-33) and Val (GTG) (TEM-34) in one strain each were substituted for Met-67 (ATG), and that in other mutants the two latter substitutions occurred together with the substitution of Asp (GAT) (TEM-35 and TEM-36) for Asn-272 (AAT). Therefore, different sets of amino acid substitutions of TEM-1 can be found in clinical isolates and lead to resistance to beta-lactamase inhibitors.Keywords
This publication has 31 references indexed in Scilit:
- Molecular epidemiology of the plasmid-encoded TEM-1 β-lactamase in ScotlandEpidemiology and Infection, 1993
- Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1992
- OHIO-1 β-lactamase resistant to mechanism-based inactivatorsFEMS Microbiology Letters, 1992
- TRC-1: Emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strainFEMS Microbiology Letters, 1992
- Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- Molecular evolution of ubiquitous β‐lactamases towards extended‐spectrum enzymes active against newer β‐lactam antibioticsMolecular Microbiology, 1990
- Comparison of vancomycin-inducible proteins from four strains of EnterococciFEMS Microbiology Letters, 1990
- Bacterial Resistance to β-Lactam Antibiotics: Crystal Structure of β-Lactamase from Staphylococcus aureus PC1 at 2.5 Å ResolutionScience, 1987
- Behaviour of TEM-1 β-lactamase as a resistance mechanism to ampicillin, mezlocillin and azlocillin in Escherichia coliJournal of Antimicrobial Chemotherapy, 1986
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975